Please note…

You are now on the ey.com Korea site. To return to the ey.com United States site or other country site, click on the Korea (English) link on the upper right of this page, and select your preferred country site.

x
Skip to main navigation

Life sciences: Driving innovation in a time of change - Ernst & Young - Korea

Life sciences

Driving innovation in a time of change

Life sciences companies — from emerging to multinational — are facing challenging times as stakeholder expectations are changing, development pipelines are declining and access to healthcare takes on new importance. Success requires flexible strategies and innovative business models.

Ernst & Young’s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential — a team with deep technical experience in providing assurance, tax, transaction and advisory services.

Whether it’s forming the right alliances, improving operations, exploring new markets or gaining industry insights, we can help you execute for success in today’s complex, competitive and risk-driven environment.

Biotechnology

Biotechnology

Biotech companies are delivering new levels of health, prosperity and sustainability across the world.

Pharmaceutical

Pharmaceutical

Key drivers are reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and evolving customer needs.

Medical Technology

Medical technology

Fundamental drivers in the global healthcare economy suggest demand for medical technology products should be robust for years to come.

Life Sciences

Contacts

Hee Hwan Lee 
Life sciences
Industry Leader
Tel: +82 2 3787 9182

Watch the Pharma 3.0 webcast 1 minute recap

Webcast: Pharma 3.0: meeting the challenge 
View a recap of our latest Pharma 3.0 discussion. Can your life sciences company improve its communications with payers and practitioners?

Businessman looking at departures in airport terminal  
Medical technology report 2011
Facing a confluence of risks, can medtech find new ways to sustain innovation? We explore. 

Back to top